pharmacy chain 36 6 (APTK:RTS)
pharmacy chain 36 6 (APTK) Snapshot
|
Open
--
|
Previous Close
$1.05
|
|
|
Day High
--
|
Day Low
--
|
|
|
52 Week High
08/15/12 - $1.12
|
52 Week Low
08/3/12 - $0.99
|
|
|
Market Cap
--
|
Average Volume 10 Days
0.0
|
|
|
EPS TTM
$-10.86
|
Shares Outstanding
105.0M
|
|
|
EX-Date
05/14/10
|
P/E TM
--
|
|
|
Dividend
--
|
Dividend Yield
--
|
Related News
pharmacy chain 36 6 (APTK) Related Businessweek News
No Related Businessweek News Foundpharmacy chain 36 6 (APTK) Details
Open Joint Stock Company Pharmacy Chain 36.6 operates as a retailer of heath and beauty products in the Russian Federation. The company’s stores retail a range of health and beauty products, as well as provide professional advice through pharmacists. As of June 30, 2012, it operated a network of 935 pharmacies, including 302 in Moscow, 235 in Urals, 152 in Volga, 159 in southern Russia, 14 in northwest Russia, and 73 in western Siberia. The company also produces and sells generic pharmaceuticals, oncology drugs, and medical plasters. Open Joint Stock Company Pharmacy Chain 36.6 was founded in 1991 and is based in Moscow, the Russian Federation.
pharmacy chain 36 6 (APTK) Key Developments
Open Joint Stock Company Pharmacy Chain 36.6 reported consolidated earnings results for the fourth quarter and fiscal year 2012. The company reduced its net loss to International Financial Reporting Standards by about 80% year-on-year to RUB 7 million in the fourth quarter of 2012. The company's net loss for 2012 was decreased by 6% to RUB 971 million. The company had a net profit after minority interest (minority shareholders of Veropharm) of RUB 1.038 billion in 2012, compared to a loss in the previous year. The company's operating profit grew 33% to RUB 2.337 billion. The company's consolidated net sales slumped 2% to RUB 20.923 billion in 2012. The company's net debt, less cash balances on accounts, totaled RUB 8.914 billion. The company's investments in fixed and intangible assets totaled RUB 1.356 billion in 2012, including RUB 274 million invested in opening and rebranding retail pharmacies.
Open Joint Stock Company Pharmacy Chain 36.6 is in talks with creditors on refinancing its debt, a company source told Interfax. The company is negotiating with its major creditors, including Sberbank of Russia and Credit Bank of Moscow. The company's main creditor is Sberbank, which in 2011 issued it a 4.15-billion-ruble credit on collateral of a controlling stake in Pharmacy Chain 36.6's only profitable asset - OJSC VeroPharm. The credit is available until the end of 2015. Pharmacy Chain 36.6 considered refinancing the loan by selling its production asset, and Russia's Federal Anti-Monopoly Service (FAS) cleared AFK Sistema to buy out VeroPharm last November. However, the deal was later suspended because the companies were unable to agree on the price. Pharmacy Chain 36.6 also took out a loan from Nomos-Bank worth RUB 1.2 billion in 2010, which was originally available until 2013. However, the company later extended the loan to 2014.
Open Joint Stock Company Pharmacy Chain 36.6 Presents at Russian Retail Forum 2013, Mar-18-2013 10:15 AM. Venue: Marriott Grand Hotel, Moscow, Russia. Speakers: Alexandra Vanthier, Portfolio Development Director.
| Recently Viewed | |||
| APTK:RU | $1.05 USD | 0.00 |  |
| Company | Last | Change | |
| No competitor information is available for APTK. | |||
| View Industry Companies | |||
Industry Analysis
APTK
Industry Average
| Valuation | APTK | Industry Range |
| Price/Earnings | -- | Not Meaningful |
| Price/Sales | -- | Not Meaningful |
| Price/Book | -- | Not Meaningful |
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | NM | Not Meaningful |
Post a JobJobs
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
- New York, NY | New York UniversityPosted: Apr 19
Sponsored Financial Commentaries
Sponsored Links
To contact PHARMACY CHAIN 36 6, please visit www.pharmacychain366.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
